Gecina (LON:0OPE)
82.65
+0.70 (0.85%)
At close: Oct 20, 2025
Gecina Revenue
Gecina had revenue of 463.60M EUR in the half year ending June 30, 2025, with 7.56% growth. This brings the company's revenue in the last twelve months to 865.37M, up 6.32% year-over-year. In the year 2024, Gecina had annual revenue of 844.38M with 5.23% growth.
Revenue (ttm)
865.37M EUR
Revenue Growth
+6.32%
P/S Ratio
7.23
Revenue / Employee
1.83M EUR
Employees
473
Market Cap
5.36B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 844.38M | 41.99M | 5.23% |
| Dec 31, 2023 | 802.39M | 58.44M | 7.85% |
| Dec 31, 2022 | 743.95M | 975.00K | 0.13% |
| Dec 31, 2021 | 742.98M | -47.70M | -6.03% |
| Dec 31, 2020 | 790.68M | -31.41M | -3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |